MEDTIDE (HKEX: 03880) has released its Monthly Return for Equity Issuer for the period ended 30 June 2026, confirming stability in its share structure and continued adherence to Hong Kong’s public-float requirements.

The company’s issued H-share capital closed the month at 141.80 million shares with a par value of RMB 1.00 each, unchanged from May 2026. No new shares were issued, cancelled, or repurchased, and MEDTIDE held no treasury shares during the period.

Total registered share capital stood at RMB 141.80 million, mirroring the issued share count. According to the filing, MEDTIDE met the Main Board’s minimum public-float requirement of 25% as at 30 June 2026.

The report recorded no activity under share option schemes, warrants, convertible instruments, or other equity-linked agreements, underscoring a static capital structure for the month.

The return was submitted by Joint Company Secretary Ng Tung Ching Raphael on 6 July 2026, fulfilling the company’s monthly disclosure obligations to Hong Kong Exchanges and Clearing Limited.